The most expensive colleges in 2025 are again setting records for the price of tuition. The sticker price of some of these colleges is extreme, with over half of the…
Investment
-
-
Investment
Your Mind Would Not Lead You to Buy Money Market Funds over a Pimco GIS Income Fund in 2017.
I wrote a couple of thoughts about different angle of this income unit trust Pimco GIS Income recently. In one of the article, someone by the name of K commented…
-
My net worth increases to S$1.867 million after CPF contributions, dividends collected and salary savings. There is a boost from the resurgence of stock markets after the trade war situation…
-
May 15, 2025 (Investorideas.com Newswire) Donald Trump has boldly imposed a new era of US economic policy dominated by tariffs, trade wars, and threats to the sovereignty of nations it…
-
As the global energy transition accelerates, the mining sector is increasingly navigating a complex landscape of shifting demand, volatile prices and growing sustainability priorities. During an S&P Global webinar on…
-
Key Points MAGA accounts are a proposed federal savings account for children under 8, capped at $5,000 per year and limited to index fund investments. The accounts would allow tax-advantaged…
-
Work has been a little stressful and sian recently and since i haven’t write about some personal finance stuff, this article will be it. I recently linked up my friend…
-
Investment
New 6-Month Singapore T-Bill Yield in Mid-May 2025 Should Fall Further to 2.25% (for the Singaporean Savers)
A Singapore Treasury Bill issue (BS25110H) will be auctioned on Thursday,22nd May 2025. If you wish to subscribe successfully, you must place your order via Internet banking (Cash, SRS, CPF-OA,…
-
May 14, 2025 (Investorideas.com Newswire) S&P 500 bullish gap thanks to correct reading of willingness of both US and China to deescalate late last week. The phase one announcement extended…
-
Investment
Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone
The approvals are supported by results of the pivotal Phase 3 SELECT-GCA clinical trial, which met the primary endpoint of sustained remission* (46.4% of patients receiving RINVOQ 15 mg in…
